progesterone: be given during pregnancy

from Quasimodo
0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Related concepts

Parents hormone
Weight: 0.73
, drug
Weight: 0.57
, ingredient
Weight: 0.56
, substance
Weight: 0.55
Siblings estrogen
Weight: 0.39
, glucocorticoid
Weight: 0.39
, oxytocin
Weight: 0.39
, vasopressin
Weight: 0.38
, prolactin
Weight: 0.38

Related properties

Property Similarity
be given during pregnancy 1.00
be given in pregnancy 0.98
during pregnancy 0.95
be needed during pregnancy 0.94
be important during pregnancy 0.94
be taken during pregnancy 0.94
be produced during pregnancy 0.93
be used in pregnancy 0.93
be in pregnancy 0.92
be needed in pregnancy 0.92

Priors about this statement

Cues

0.2 0.4 0.6 0.8 Joint Necessity Sufficiency Implication Entailment Contradiction Entropy

Evidence

0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Clauses

Remarkability exclusitivity between siblings

0.12
Rule weight: 0.13
Evidence weight: 0.96
Similarity weight: 0.93
Evidence: 0.90
¬ Remarkable(progesterone, be given during pregnancy)
Evidence: 0.05
¬ Remarkable(oxytocin, be used in pregnancy)

Remarkability from sibling implausibility

0.55
Rule weight: 0.60
Evidence weight: 0.98
Similarity weight: 0.93
Evidence: 0.50
Plausible(progesterone, be given during pregnancy)
Evidence: 0.05
Remarkable(oxytocin, be used in pregnancy)
Evidence: 0.04
¬ Plausible(oxytocin, be used in pregnancy)

Salient implies Plausible

0.18
Rule weight: 0.28
Evidence weight: 0.63
Similarity weight: 1.00
Evidence: 0.50
Plausible(progesterone, be given during pregnancy)
Evidence: 0.74
¬ Salient(progesterone, be given during pregnancy)

Similarity expansion

0.76
Rule weight: 0.85
Evidence weight: 0.91
Similarity weight: 0.98
Evidence: 0.90
Remarkable(progesterone, be given during pregnancy)
Evidence: 0.88
¬ Remarkable(progesterone, be given in pregnancy)
0.75
Rule weight: 0.85
Evidence weight: 0.93
Similarity weight: 0.94
Evidence: 0.90
Remarkable(progesterone, be given during pregnancy)
Evidence: 0.71
¬ Remarkable(progesterone, be important during pregnancy)
0.74
Rule weight: 0.85
Evidence weight: 0.91
Similarity weight: 0.95
Evidence: 0.90
Remarkable(progesterone, be given during pregnancy)
Evidence: 0.90
¬ Remarkable(progesterone, during pregnancy)
0.74
Rule weight: 0.85
Evidence weight: 0.92
Similarity weight: 0.94
Evidence: 0.90
Remarkable(progesterone, be given during pregnancy)
Evidence: 0.85
¬ Remarkable(progesterone, be needed during pregnancy)
0.73
Rule weight: 0.85
Evidence weight: 0.91
Similarity weight: 0.94
Evidence: 0.90
Remarkable(progesterone, be given during pregnancy)
Evidence: 0.89
¬ Remarkable(progesterone, be taken during pregnancy)
...

Typical and Remarkable implies Salient

0.13
Rule weight: 0.14
Evidence weight: 0.92
Similarity weight: 1.00
Evidence: 0.74
Salient(progesterone, be given during pregnancy)
Evidence: 0.35
¬ Typical(progesterone, be given during pregnancy)
Evidence: 0.90
¬ Remarkable(progesterone, be given during pregnancy)

Typical implies Plausible

0.40
Rule weight: 0.48
Evidence weight: 0.83
Similarity weight: 1.00
Evidence: 0.50
Plausible(progesterone, be given during pregnancy)
Evidence: 0.35
¬ Typical(progesterone, be given during pregnancy)

Typicality and Rermarkability incompatibility between siblings

0.10
Rule weight: 0.14
Evidence weight: 0.80
Similarity weight: 0.93
Evidence: 0.90
¬ Remarkable(progesterone, be given during pregnancy)
Evidence: 0.23
¬ Typical(oxytocin, be used in pregnancy)